Stocks
CVS Health Corporation Financial Statements (CVS) |
||||||||||
| CVS Health Corporationsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 18.02.2020 | 16.02.2021 | 09.02.2022 | 08.02.2023 | 07.02.2024 | 01.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 256 776 | 268 706 | 292 111 | 322 467 | 357 776 | 360 935 | |||
| Operating Income, bln rub | 11 987 | 13 911 | 13 193 | 16 251 | 13 743 | 12 568 | ||||
| EBITDA, bln rub | ? | 16 482 | 18 558 | 19 676 | 20 498 | 19 053 | 16 509 | |||
| Net profit, bln rub | ? | 6 634 | 7 179 | 8 001 | 4 311 | 8 344 | 7 321 | |||
| OCF, bln rub | ? | 12 848 | 15 865 | 18 265 | 16 177 | 13 426 | 10 891 | |||
| CAPEX, bln rub | ? | 2 457 | 2 437 | 2 520 | 2 727 | 3 031 | 2 752 | |||
| FCF, bln rub | ? | 10 391 | 13 428 | 15 745 | 13 450 | 10 395 | 8 139 | |||
| Dividend payout, bln rub | 2 603 | 2 624 | 2 625 | 2 907 | 3 132 | 3 193 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 39.2% | 36.6% | 32.8% | 67.4% | 37.5% | 43.6% | ||||
| OPEX, bln rub | 33 541 | 35 135 | 37 066 | 38 212 | 39 832 | 40 542 | ||||
| Cost of production, bln rub | 211 248 | 219 660 | 240 063 | 268 173 | 303 345 | 371 893 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 3 035 | 2 907 | 2 503 | 2 287 | 2 658 | 2 785 | ||||
| Assets, bln rub | 222 449 | 230 715 | 232 999 | 228 275 | 249 728 | 249 743 | ||||
| Net Assets, bln rub | ? | 63 864 | 69 389 | 75 075 | 71 015 | 76 461 | 73 968 | |||
| Debt, bln rub | 89 002 | 85 042 | 75 999 | 70 732 | 79 385 | 81 792 | ||||
| Cash, bln rub | 8 056 | 10 854 | 12 525 | 15 723 | 11 455 | 13 089 | ||||
| Net debt, bln rub | 80 946 | 74 188 | 63 474 | 55 009 | 67 930 | 68 703 | ||||
| Ordinary share price, rub | 74.3 | 68.3 | 103.2 | 93.2 | 79.0 | 69.7 | ||||
| Number of ordinary shares, mln | 1 301 | 1 309 | 1 319 | 1 312 | 1 285 | 1 260 | ||||
| Market cap, bln rub | 96 651 | 89 405 | 136 068 | 122 265 | 101 464 | 87 784 | ||||
| EV, bln rub | ? | 177 597 | 163 593 | 199 542 | 177 274 | 169 394 | 156 487 | |||
| Book value, bln rub | -49 006 | -41 305 | -33 072 | -31 889 | -44 045 | -46 074 | ||||
| EPS, rub | ? | 5.10 | 5.48 | 6.07 | 3.29 | 6.49 | 5.81 | |||
| FCF/share, rub | 7.99 | 10.3 | 11.9 | 10.3 | 8.09 | 6.46 | ||||
| BV/share, rub | -37.7 | -31.6 | -25.1 | -24.3 | -34.3 | -36.6 | ||||
| EBITDA margin, % | ? | 6.42% | 6.91% | 6.74% | 6.36% | 5.33% | 4.57% | |||
| Net margin, % | ? | 2.58% | 2.67% | 2.74% | 1.34% | 2.33% | 2.03% | |||
| FCF yield, % | ? | 10.8% | 15.0% | 11.6% | 11.0% | 10.2% | 9.27% | |||
| ROE, % | ? | 10.4% | 10.3% | 10.7% | 6.07% | 10.9% | 9.90% | |||
| ROA, % | ? | 2.98% | 3.11% | 3.43% | 1.89% | 3.34% | 2.93% | |||
| P/E | ? | 14.6 | 12.5 | 17.0 | 28.4 | 12.2 | 12.0 | |||
| P/FCF | 9.30 | 6.66 | 8.64 | 9.09 | 9.76 | 10.8 | ||||
| P/S | ? | 0.38 | 0.33 | 0.47 | 0.38 | 0.28 | 0.24 | |||
| P/BV | ? | -1.97 | -2.16 | -4.11 | -3.83 | -2.30 | -1.91 | |||
| EV/EBITDA | ? | 10.8 | 8.82 | 10.1 | 8.65 | 8.89 | 9.48 | |||
| Debt/EBITDA | 4.91 | 4.00 | 3.23 | 2.68 | 3.57 | 4.16 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.96% | 0.91% | 0.86% | 0.85% | 0.85% | 0.76% | ||||
| CVS Health Corporation shareholders | ||||||||||
